|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on prevention and screening of cervical cancer显示文摘Cervical cancer is the third most common cause of cancer in women in the world. During the past few decades tremendous strides have been made toward decreasing the incidence and mortality of cervical cancer with the implementation of various prevention and screening strategies. The causative agent linked to cervical development and its precursors is the human papillomavirus(HPV). Prevention and screening measures for cervical cancer are paramount because the ability to identify and treat the illness at its premature stage often disrupts the process of neoplasia. Cervical carcinogenesis can be the result of infections from multiple high-risk HPV types that act synergistically. This imposes a level of complexity to identifying and vaccinating against the actual causative agent. Additionally, most HPV infections spontaneously clear. Therefore, screening strategies should optimally weigh the benefits and risks of screening to avoid the discovery and needless treatment of transient HPV infections. This article provides an update of the preventative and screening methodsfor cervical cancer, mainly HPV vaccination, screening with Pap smear cytology, and HPV testing. It also provides a discussion of the newest United States 2012 guidelines for cervical cancer screening, which changed the age to begin and end screening and lengthened the screening intervals. | Shaniqua L Mc Graw Jeanne M Ferrante | 2014 | World Journal of Clinical Oncology2014，5，4： | 17 |
| 2 | Soy-based renoprotection显示文摘Chronic kidney disease(CKD) is a significant publich ealth problem as risk factors such as advanced age, obesity, hypertension and diabetes rise in the global po-pulation. Currently there are no effective pharmacologic treatments for this disease. The role of diet is important for slowing the progression of CKD and managing symptoms in later stages of renal insufficiency. While low protein diets are generally recommended, maintaining adequate levels of intake is critical for health. There is an increasing appreciation that the source of protein may also be important. Soybean protein has been the most extensively studied plant-based protein in subjects with kidney disease and has demonstrated renal protective properties in a number of clinical studies. Soy protein consumption has been shown to slow the decline in estimated glomerular filtration rate and significantly improve proteinuria in diabetic and non-diabetic patients with nephropathy. Soy's beneficial effects on renal function may also result from its impact on certain phy-siological risk factors for CKD such as dyslipidemia, hypertension and hyperglycemia. Soy intake is also associated with improvements in antioxidant status and systemic inflammation in early and late stage CKD pati-ents. Studies conducted in animal models have helped to identify the underlying molecular mechanisms that may play a role in the positive effects of soy protein on renal parameters in polycystic kidney disease, metabolically-induced kidney dysfunction and age-associated prog-ressive nephropathy. Despite the established relationship between soy and renoprotection, further studies are needed for a clear understanding of the role of the cellular and molecular target(s) of soy protein in main-taining renal function. | Nancy J Mc Graw Elaine S Krul Elizabeth Grunz-Borgmann Alan R Parrish | 2016 | World Journal of Nephrology2016，5，3： | 5 |
| 3 | Prospective evaluation of pain relief in 100 patients undergoing pereutaneous Vertebroplasty,results and Tollow- up显示文摘 | Me Graw JK Lippet JA Minkus KD | 2002 | J Vase Interv Hadiol2002，13，88： | 1 |
| 4 | The association of leukocyte count, fibrinogen and C reactive prolein with vascular risk factors and ischemic vascular disease显示文摘 | Graw AJ Buggle F Becher H | 1996 | Thromb Res1996，82，： | 1 |
| 5 | Lung volume reduction surgery:An overview显示文摘 | Mc Graw LR | 1997 | Heart lung1997，26，2： | 1 |
| 6 | Cadmium in milk and mammary gland in rats and mice显示文摘 | Kierstin Petersson Grawe | 2000 | Arch Toxicol2000，73，： | 1 |
| 7 | Structural and bio mechanical responses of osseous healing: a novel murine nonun- ion model显示文摘 | Chaubey A Grawe B Meganck J A | 2013 | J Orthop Traumatol2013，14，4： | 1 |
| 8 | Cadmium in milk and mammary gland in rats and mice 显示文摘 | Kierstin Petersson Grawe | 2000 | Arch Toxicol2000，73，： | 1 |
| 9 | Genetics of crystallins:Cataract and beyond显示文摘 | Graw J | | 0，，02： | 1 |
| 10 | Cadmium in food chain and health effects in sensitive population groups显示文摘 | Agneta Oskarsson Anna Widell Ing-Marie Olsson Kierstin Petersson Grawé | 2004 | BioMetals2004，，5： | 1 |
| 11 | Induction of micronuclei in mouse and rat by glycidamide, genotoxic mctabolite of acrylamide显示文摘 | PAULSSON B KOTOVA N GRAWE J | 2003 | Mutat Res2003，535，1： | 1 |
| 12 | Forming inferences about some intraclass correlation coefficients显示文摘 | Mc Graw K Wong S | 1996 | Psychological Methods1996，1，1： | 1 |
| 13 | Minimal incision surgery as a risk factor for early failure of total hip arthroplasty 显示文摘 | Graw BP Woolson ST Huddleston HG | 2010 | Clin Orthop Relat Res2010，468，9： | 1 |
| 14 | Southwest On Cology Group studies in blader显示文摘 | Graw fard ED Wood DP Petrgak DP | | 0，，08： | 1 |
| 15 | Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P显示文摘 | Graw J Klopp N Illig T | | 0，，08： | 1 |
| 16 | Water and air in two poultry processing plants' chilling facilities:a bacteriological survey显示文摘 | PRIES R GRAW C | | 0，，： | 1 |
| 17 | Genetics of crystallins:cataract and beyond显示文摘 | Graw J | | 0，，： | 1 |
| 18 | 8p23 duplication reconsidered: is it a true euchromatic variant with no clinical manifestation? 显示文摘 | Tsai C H Graw S L McGavran L | 2002 | J Med Genet2002，39，10： | 1 |
| 19 | Characterization of a new dominant V124E mutation in the mouse a A-crystallin-encoding gene显示文摘 | Graw J Loster J Soewarto D | | 0，，12： | 1 |
| 20 | The muhiplicative model for cancer risk assessment:aplicability to acrylamide显示文摘 | Paulsson B Granath F Grawe J | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员